EP4301468

FGFR3 HEMLANDI EFNASAMBÖND

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    3.3.2022
  • EP published:
    3.9.2025
  • EP application number:
    22712686.9
  • Max expiry date:
    2.3.2042
  • Expiry date:
    2.3.2027
  • Next due date:
    31.3.2027
  • Title in English:
    FGFR3 INHIBITOR COMPOUNDS
  • Language of the patent:
    English

Timeline

Today
3.3.2022EP application
3.9.2025EP Publication
26.11.2025Translation submitted
15.12.2025Registration published
2.3.2027Expires

Owner

  • Name:
    Eli Lilly and Company
  • Address:
    Lilly Corporate Center, Indianapolis, IN 46285, US

Inventor

  • Name:
    ABRAHAM, Adedoyin David
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    BUME, Desta Doro
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    CONDROSKI, Kevin Ronald
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    DILGER, Andrew Karl
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    HAZLITT, Robert Alan
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    KERCHER, Timothy Scott
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    METCALF, Andrew Terrance
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    URKALAN, Kaveri Balan
  • Address:
    Indianapolis, Indiana 46206-6288, US
  • Name:
    WALLS, Shane Michael
  • Address:
    Indianapolis, Indiana 46206-6288, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    202163156527 P
  • Date:
    4.3.2021
  • Country:
    US

Classification

  • Categories:
    A61P 35/00, C07D 471/04

Annual fees

Number

Paid

Expires

Payer

Number: 5

Paid: 5.3.2026

Expires: 2.3.2027

Payer: Árnason Faktor ehf.

Upload documents